About Lepu Medical Technology
Lepu Medical Technology is a company based in Beijing (China) founded in 1999. The company has 8,810 employees. Lepu Medical Technology operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Spectrum Dynamics and Proxim Diagnostics, among others.
- Headquarter Beijing, China
- Employees 8,810
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lepumedical.com
- Social LinkedIn Facebook
- Legal Name Lepu Medical Technology (Beijing) Co., Ltd. Class A
- Annual Revenue$918.44 M (USD)6.28as on Dec 31, 2025
- Net Profit$137.41 M (USD)289.57as on Dec 31, 2025
- EBITDA$278.53 M (USD)82.1as on Dec 31, 2025
- Latest Funding Round$185.83M (USD), Post-IPO
Aug 2020
- InvestorsHaitong Securities
& 6 more
- Employee Count8,810
Funding Insights of Lepu Medical Technology
- Total Rounds 3
- Last Round Post-IPO — $185.83M
- First Round $130M
(Jul 2019)
- Investors Count 7
All 3 funding rounds of Lepu Medical Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $185.83M | Post-IPO | – | – | |
| Apr 2020 | – | Post-IPO | – | – | – |
| Jul 2019 | $130M | Post-IPO | – | – |
7 investors in total: 7 institutional.
Investors in Lepu Medical Technology
Lepu Medical Technology has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Haitong Securities, RiverHead Capital and SDIC Unity Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on multiple sectors | – | riverheadcapital.cn | Beijing, China | |
A professional guiding and industrial fund management institution is operated. | – | sdicfof.com | China | |
Technology, manufacturing, healthcare, and consumer companies are provided growth equity. | – | chinareformfund.com | Haidian, China | |
Shiyu Capital is engaged in equity investment and asset allocation. | – | shiyucapital.com | Beijing, China | |
Financial services such as brokerage and asset management are offered. | 1988 | htsec.com | Shanghai, China | |
Functions as an investment firm managing diversified funds and portfolios. | 2016 | jsmytz.com | Wuxi, China | |
Shareate is engaged in manufacturing rock drilling tools and carbide materials. | 2005 | shareate.com | Suzhou, China |
Investor details for Lepu Medical Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lepu Medical Technology
1 people are tracked at Lepu Medical Technology (1 in leadership); the tracked headcount is 8,810.
| Name | Role | Group |
|---|---|---|
Pu Zhongjie | Chairman & CEO | Leadership |
Complete people profiles for Lepu Medical Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Lepu Medical Technology
Lepu Medical Technology is a publicly listed company on the SZSE with ticker symbol 300003 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Nov 2022
- Listed onHKG: 2291
- Listed entityLepu Medical Technology (Beijing) Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100000H44
- Share price11.68 CNY (+1.92% on the day) · 2026-10-09
- Market capitalisation20,699,156,047.00 CNY
- Price to earnings27.9
- EPS (diluted, trailing year)0.42 CNY
- Dividend yield2.84%
- Volume (last session)15,713,312
Financials of Lepu Medical Technology
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 6.43B CNY | 962.0M CNY | 1.95B CNY |
| 2024 | 6.05B CNY | 246.9M CNY | 1.07B CNY |
| 2023 | 7.92B CNY | 1.26B CNY | 2.17B CNY |
| 2022 | 10.52B CNY | 2.20B CNY | 3.27B CNY |
| 2021 | 10.57B CNY | 1.72B CNY | 3.11B CNY |
Detailed financial statements for Lepu Medical Technology
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Lepu Medical Technology
4 dated milestones of Lepu Medical Technology across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Lepu Medical Technology is founded.
- Funding First funding round of $130.0M.
- Funding Latest funding round, Post-IPO, of $185.8M.
- IPO Lists on the stock exchange (IPO).
Competitors of Lepu Medical Technology
Lepu Medical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Spectrum Dynamics and Proxim Diagnostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genincode.com | 2018 | Manchester, United Kingdom | $4.48M | 26 | Genetic and clinical data are integrated for precision cardiac medicines. | |
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| spectrum-dynamics.com | 2000 | Morges, Switzerland | – | – | Cardiac imaging systems are manufactured using advanced molecular technologies. | |
| proximdx.com | 2010 | Sunnyvale, United States | $22.9M | – | Handheld immunodiagnostic devices for cardiac vascular diseases are developed. | |
| bostonheartdiagnostics.com | 2007 | Framingham, United States | $10.34M | – | Diagnostics for personalized cardiovascular disease management are developed. | |
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | – | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. | |
| diadexus.com | 1997 | San Francisco, United States | $49.2M | – | Molecular diagnostic tests for cardiovascular disorders are developed and marketed. | |
| realviewimaging.com | 2008 | Yokneam Illit, Israel | $25M | – | 3D holographic display solutions for medical imaging are provided. |
Detailed competitors of Lepu Medical Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lepu Medical Technology
The website of Lepu Medical Technology (lepumedical.com) receives about 39.5K visits a month.
- Monthly visits39.5K
▼ 21% vs previous month
Websites whose visitors overlap most with Lepu Medical Technology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ro-med.ru | ro-med.ru | 100% | – | #1,290,471 | – |
| interlabservice.ru | 93% | 11.3K | #2,219,081 | View details | |
| wandong.com.cn | 92% | 1.7K | #10,145,404 | View details | |
basismed.ru | basismed.ru | 92% | – | #10,129,798 | – |
| yuwell.com | 87% | 109.4K | #267,618 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Lepu Medical Technology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Lepu Medical Technology
Complete news archive for Lepu Medical Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Lepu Medical Technology
10 companies that operate in the same segment as Lepu Medical Technology (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lepu Medical Technology
Lepu Medical Technology was founded in 1999 and raised its 1st funding round 20 years after it was founded.
Lepu Medical Technology is headquartered in Beijing, China.
Pu Zhongjie is the current CEO of Lepu Medical Technology.
Lepu Medical Technology has 8,810 employees.
Annual revenue of Lepu Medical Technology is $918.44M as on Dec 31, 2025.
Lepu Medical Technology is engaged in the development, manufacturing, and marketing of cardiac therapy related products. The company offers products under eight main categories: Interventional cardiology (Stent, Balloon, Catheter, and Guidewire); Structural heart disease (occlusion devices, prosthetic heart valves); Heart rhythm (Electrophysiology catheter, Implantable pacemaker, Pacemaker lead); cardiac in vitro diagnosis products (analyzer, cardiac biomarkers test cassette, Thrombelastography hemostasis analyzer), Anesthetic products, Interventional angiography system, Surgical stapler, and Neurological intervention products. The company has 7 wholly-owned and joint stock subsidiary companies.
Lepu Medical Technology's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Yes, Lepu Medical Technology is publicly traded on SZSE under the ticker symbol 300003.
Lepu Medical Technology has 7 investors. Key investors include Haitong Securities, RiverHead Capital, SDIC Unity Capital, China Reform Fund Management, and Shiyu Capital.